Detailed View
NRIX - Nurix Therapeutics, Inc.
Latest filing: 2026-08-31 | Reporting: gaap
Market Cap
2,585,943,040
Adj EBIT (TTM)
330,312,000
Enterprise Value
1,537,688,040
Last Price
23.67
Earnings Yield
21.48%
Return on Capital
31.03%
Capital
1,064,556,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-08-31 | 10-Q | 2026 | 673,064,000 | 559,451,000 |
| 2026-05-31 | 10-Q | 2026 | 9,043,000 | -94,204,000 |
| 2026-02-28 | 10-Q | 2026 | 6,252,000 | -92,495,000 |
| 2025-11-30 | 10-K (Q4 derived) | 2025 | 13,577,000 | -83,095,000 |
| 2025-08-31 | 10-Q | 2025 | 7,894,000 | -91,385,000 |
| 2025-05-31 | 10-Q | 2025 | 44,056,000 | -48,322,000 |
| 2025-02-28 | 10-Q | 2025 | 18,453,000 | -62,864,000 |
| 2024-11-30 | 10-K (Q4 derived) | 2024 | 13,284,000 | -64,657,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.